-
Founded in:
2004-07-09 -
Country:
China -
Address:
Building 1, No. 29, Yingbin Avenue, Huai'an Economic and Technological Development Zone -
Tax NO.:
91320803762805163T -
Registered Funds:
10.15 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lafutidine |
It is an H2 receptor blocker. It can continuously inhibit gastric acid secretion and act on the capsaicin-sensitive afferent neurons in the gastric mucosa to protect the gastric mucosa, promote mucosal repair, increase gastric mucosal blood flow and increase gastric mucus secretion.
More
It is an H2 receptor blocker. It can continuously inhibit gastric acid secretion and act on the capsaicin-sensitive afferent neurons in the gastric mucosa to protect the gastric mucosa, promote mucosal repair, increase gastric mucosal blood flow and increase gastric mucus secretion. |
118288-08-7 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Palmatine |
|
3486-67-7 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Palmatine |
|
3486-67-7 | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| FRITILLARIAE THUNBERGII BULBUS |
|
0 | ||
| Paeoniae Rubra |
|
0 | ||
| Bupleurum |
|
0 | ||
| Prunella vulgaris |
|
0 | ||
| CURCUMAE RADIX |
|
0 | ||
| Angelicae Sinensis Radix |
|
0 | ||
| Swisscentaury Root Extract |
|
0 | ||
| Semen Citri Reticulatae extract |
|
0 | ||
| CYPERI RHIZOMA |
|
0 | ||
| Rubiae Radix et Rhizoma |
|
0 | ||
| LUFFAE FRUCTUS RETINERVUS |
|
0 | ||
| DGL |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Finasteride |
It is a 4-nitrogen steroid hormone compound and a specific type II 5α-reductase competitive inhibitor. It inhibits the conversion of peripheral testosterone into dihydrotestosterone and reduces the level of dihydrotestosterone in the blood, prostate, skin and other tissues. It inhibits prostate hyperplasia and improves the clinical symptoms related to benign prostatic hyperplasia by reducing the level of dihydrotestosterone in the blood and prostate tissue.
More
It is a 4-nitrogen steroid hormone compound and a specific type II 5α-reductase competitive inhibitor. It inhibits the conversion of peripheral testosterone into dihydrotestosterone and reduces the level of dihydrotestosterone in the blood, prostate, skin and other tissues. It inhibits prostate hyperplasia and improves the clinical symptoms related to benign prostatic hyperplasia by reducing the level of dihydrotestosterone in the blood and prostate tissue. |
98319-26-7 | 51 |